InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,608.25
(
0.97%
)
US TECH 100
19,266.00
(
0.08%
)
Dow Jones
40,896.53
(
0.58%
)
Brent Oil
76.52
(
-1.11%
)
Bitcoin
60,955.48
(
2.49%
)
Post# of 252925
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

go seek

Send PM Follow Ignore
Followers 21
Posts 4809
Boards Moderated 0
Alias Born 06/24/2006

go seek

Member Level

Re: upndown1313 post# 48494

Wednesday, 06/13/2007 2:32:14 PM

Wednesday, June 13, 2007 2:32:14 PM

Post# of 252925
IDIX perhaps... but pls show me where in the the last 6 months, management said a successful interaction study means an automatic move to Phase 3 with NM283...

Also the data reported was on a treatable basis as per study design protocol and the PR stated this.

I too am disappointed that IDIX moved down... and it was because of the delay.

Idenix has a lot of positives...
as you know Idenix is not paying for the trials, so they must clear all development w/ Novartis.

The trial met the endpoints for which it was designed.

Best wishes
long IDIX


The creation of a thousand forests is in one acorn.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up